Liver cT1 predicts clinical outcomes in patients with chronic liver disease, equivalent to biopsy

Liver cT1 predicts clinical outcomes in patients with chronic liver disease, equivalent to biopsy

Bibliografske podrobnosti
Main Authors:	Jayaswal, A, Pavlides, M, Banerjee, R, Kelly, M, Barnes, E, Neubauer, S
Format:	Conference item
Izdano:	Wiley 2018

Podobne knjige/članki

Liver cT1 predicts clinical outcomes in patients with chronic liver disease
od: Jayaswal, A, et al.
Izdano: (2019)

Liver cT1 decreases following direct acting antiviral therapy in patients with chronic hepatitis C virus
od: Jayaswal, A, et al.
Izdano: (2020)

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
od: Pavlides, M, et al.
Izdano: (2015)

Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique".
od: Pavlides, M, et al.
Izdano: (2016)

Multi-parametric MRI predicts clinical outcomes in unselected patients with liver disease - a non-invasive test that meets the AASLD criteria for clinical trials?
od: Pavlides, M, et al.
Izdano: (2014)

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
od: Jayaswal, ANA, et al.
Izdano: (2020)

Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?
od: Chin, J, et al.
Izdano: (2016)

ACOUSTIC RADIATION FORCE IMPULSE IS EQUIVALENT TO LIVER BIOPSY TO EVALUATE LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C AND NONALCOHOLIC FATTY LIVER DISEASE
od: Juliana Ayres de Alencar Arrais GUERRA, et al.
Izdano: (2015-09-01)

Usefulness of liver biopsy in chronic hepatitis C
od: Edna Strauss
Izdano: (2010-01-01)

Liver function assessment using magnetic resonance imaging with gadoxetic acid administration
od: Levick, C, et al.
Izdano: (2018)

Liver Biopsies for Chronic Hepatitis C: Should Nonultrasound-Guided Biopsies Be Abandoned?
od: Jennifer A Flemming, et al.
Izdano: (2009-01-01)

Estimation of Liver Collagen Proportionate Area by Visual Inspection
od: Pavlides, M, et al.
Izdano: (2014)

Estimation of Liver Collagen Proportionate Area by Visual Inspection
od: Pavlides, M, et al.
Izdano: (2014)

Usefulness of liver biopsies in chronic infection with hepatitis C virus
od: Jesús Aguirre García
Izdano: (2006-01-01)

Comparison Between Liver Biopsy And Hyaluronic Acid In Chronic Liver Disease
od: Saeed Akhtar Tunio, et al.
Izdano: (2024-05-01)

Impact of CT texture analysis on complication rate in CT-guided liver biopsies
od: Maike Niebur, et al.
Izdano: (2024-01-01)

Quantifying the heterogeneity of liver inflammation and fibrosis in primary sclerosing cholangitis using the interquartile range of iron‐corrected T1 from multi‐parametric MRI
od: Selvaraj, E, et al.
Izdano: (2019)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
od: Pavlides, M, et al.
Izdano: (2017)

A model for hepatic fibrosis: The competing effects of cell loss and iron on shortened Modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver
od: Tunnicliffe, E, et al.
Izdano: (2016)

Interobserver variability in histologic evaluation of liver fibrosis using categorical and quantitative scores
od: Pavlides, M, et al.
Izdano: (2017)

Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases
od: Makoto Iijima, et al.
Izdano: (2021-01-01)

Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance?
od: Dominique Larrey, et al.
Izdano: (2017-07-01)

Clinical Relevance of Transjugular Liver Biopsy in Comparison with Percutaneous and Laparoscopic Liver Biopsy
od: Max G. Beckmann, et al.
Izdano: (2009-01-01)

Liver Enzymes as Surrogate Markers of Hepatitis C Histopathology – Avoiding the Liver Biopsy Needle?
od: Stephen GM Wong, et al.
Izdano: (2001-01-01)

Diagnostic value of Transient Elastography (Fibroscan) in the evaluation of liver fibrosis in chronic viral hepatitis C: Comparison to liver biopsy
od: Mona El-Hariri, et al.
Izdano: (2017-06-01)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
od: Savic, D, et al.
Izdano: (2020)

From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
od: Cătălina Diaconu, et al.
Izdano: (2015-08-01)

Outcomes following renal transplantation in patients with chronic hepatitis C based on severity of fibrosis on pre-transplant liver biopsy
od: Nader Dbouk, et al.
Izdano: (2013-01-01)

THE DIAGNOSIS OF LIVER ALLOGRAFT ACUTE REJECTION IN LIVER BIOPSIES
od: L. V. Shkalova, et al.
Izdano: (2011-06-01)

The role of liver biopsy for asymptomatic liver enzyme elevation
od: Le Mire, M, et al.
Izdano: (2005)

Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
od: Hesham Mohamed Atef, et al.
Izdano: (2023-12-01)

Non-alcoholic fatty liver disease
od: Pavlides, M, et al.
Izdano: (2019)

Predictors of liver fibrosis changes assessed by paired liver biopsies in chronic hepatitis C patients treated with direct-acting antivirals
od: Ming-Han Hsieh, et al.
Izdano: (2024-12-01)

Appropriateness of Liver Biopsy
od: Thierry Poynard, et al.
Izdano: (2000-01-01)

Transjugular liver biopsy
od: Antonio C. Maciel, et al.
Izdano: (2022-07-01)

Liver needle biopsy in children
od: S Ozsoylu, et al.
Izdano: (1980-01-01)

Transjugular liver biopsy: enlarge the indications for liver biopsy with reliable diagnostic quality
od: Miao-Yang Chen, et al.
Izdano: (2023-08-01)

Specific features of lymphoid infiltration in liver biopsy in patients with chronic viral hepatitis B and C
od: Karina Turakbaevna Umbetova, et al.
Izdano: (2011-11-01)

Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.
od: Mi Sung Park, et al.
Izdano: (2013-01-01)

Modern Possibilities of Endosurgical Biopsy in Children with Chronic Liver Diseases
od: Polina V. Khrolenko, et al.
Izdano: (2018-07-01)